BridgeBio Pharma, Inc. (BBIO)

Nasdaq · Healthcare · Biotechnology
$76.03-2.75%As of 2026-11-22 · USD
Last session low $75.46Last session high $78.22
52-week low $62.5052-week high $93.42
Market cap
$14.81B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)57.7In the neutral range (30 to 70)
MACD (12, 26, 9)2.17Below its signal line (2.22); histogram -0.05
Bollinger %B (20, 2)54%Inside the bands (68.90 to 82.03)
SMA 2075.47Price is 0.7% above
SMA 5070.31Price is 8.1% above
SMA 20072.77Price is 4.5% above
ATR (20)3.31% of priceAverage true range per day
52-week position44%In the middle of the 62.50 to 93.42 range

About BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.

Insider filings, 90 daysNo purchases and 2 sales (about $837K).
Latest fiscal yearEnded 2025-12-31: revenue of $502.08M and an operating margin of -100.0%.

More in Biotechnology